Judges Scientific plc (the "Company")
Exercise of Options and Director dealing
24 January 2014
The Company has today issued 37,000 new ordinary shares of 5p each in the Company ("Ordinary Shares") pursuant to the exercise of options under the Company's Unapproved Share Option Scheme. Application has been made for the new Ordinary Shares to be admitted to AIM and dealings are expected to commence on 30 January 2014.
The options were exercised by the Company's Finance Director, Ralph Cohen. They were granted when he joined the Company in October 2005. Primarily to finance the cost of exercising the options and the resulting income tax and employer's National Insurance liabilities, he has today sold 30,000 Ordinary Shares to an institution at £20.00 per Ordinary Share. The remaining 7,000 Ordinary Shares have been transferred to his wife, Morwenna Rosemary Cohen.
Mr Cohen's resulting interest in the Company is 57,913 Ordinary Shares representing 0.98 per cent. of the issued Ordinary share capital. In addition, he holds remaining options over 7,875 Ordinary Shares under the Company's Share Option Plans.
Following the allotment of these shares, the enlarged issued Ordinary share capital will be 5,900,270 Ordinary Shares.
For further information please contact:
Judges Scientific Plc
David Cicurel, CEO
Tel: 01342 323 600
Shore Capital (Nominated Adviser & Broker)
Pascal Keane
Edward Mansfield
Tel: 020 7408 4090
Cardew Group (Financial Public Relations)
Melvyn Marckus
Tel: 020 7930 0777 or 07775 896 491
or
Nadja Vetter
Tel: 020 7930 0777 or 07941 340 436
Website:
Judges Scientific: www.judges.uk.com